P33. NK-92 Cellular Immunotherapy as an Alternative to Donor Derived Peripheral Blood NK Cells

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-2-s2-p24
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Anti-Ovarian Tumor Response of Donor Peripheral Blood Mononuclear Cells Is Due to Infiltrating Cytotoxic NK Cells

Oncotarget
Oncology
2016English

Human Embryonic Stem Cell (hESC)-derived NK Cells for Cancer Immunotherapy

Science-Business eXchange
2009English

P18: Trophoblasts Promote Conversion of Peripheral NK Cells to a Decidual NK-like Phenotype

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2018English

NK Cell-Based Glioblastoma Immunotherapy

Cancers
Cancer ResearchOncology
2018English

ErbB2/HER2-specific NK Cells for Adoptive Cancer Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Exogenous Activated NK Cells Enhance Trafficking of Endogenous NK Cells to Endometriotic Lesions

BMC Immunology
Immunology
2015English

Utilizing Cytokines to Function-Enable Human NK Cells for the Immunotherapy of Cancer

Scientifica
AgriculturalEnvironmental ScienceBiological Sciences
2014English

KHYG-1 and NK-92 Represent Different Subtypes of LFA-1-mediated NK Cell Adhesiveness

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2011English

CMV and NK Cells: An Unhealthy Tryst?

Cell Host and Microbe
ImmunologyMolecular BiologyCancer ResearchVirologyMicrobiologyMicrobiology Parasitology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy